[A clinical analysis of hypothyroidism in very low birth weight/extremely low birth weight infants].


Journal

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
ISSN: 1008-8830
Titre abrégé: Zhongguo Dang Dai Er Ke Za Zhi
Pays: China
ID NLM: 100909956

Informations de publication

Date de publication:
Oct 2020
Historique:
entrez: 16 10 2020
pubmed: 17 10 2020
medline: 15 12 2020
Statut: ppublish

Résumé

To study the risk factors and treatment outcome of hypothyroidism in very low birth weight/extremely low birth weight (VLBW/ELBW) infants. The VLBW/ELBW infants who were diagnosed with hypothyroidism from September 2018 to December 2019 were enrolled as the case group (n=29). The children with normal thyroid function, matched at a ratio of 1 : 3, were enrolled as the control group (n=87). Clinical features were compared between the two groups. The correlation of thyroid function with gestational age and birth weight and the risk factors for hypothyroidism were analyzed. A total of 162 VLBW/ELBW infants who met the inclusion criteria were enrolled, with 29 infants in the case group (an incidence rate of hypothyroidism of 17.9%). The lower the birth weight, the higher the incidence rate of hypothyroidism (P<0.05). Triiodothyronine (T3) and free T3 were positively correlated with gestational age (P<0.05). T3 and free thyroxine were positively correlated with birth weight (P<0.05). Small for gestational age, multiple birth, maternal age ≥ 35 years, and use of dopamine were independent risk factors for hypothyroidism (P<0.05). In the case group, 16 infants were treated with levothyroxine (5-10 μg/kg daily), and the thyroid function returned to normal after 2 weeks of treatment. There is a high incidence rate of hypothyroidism in VLBW/ELBW infants. Small for gestational age, multiple birth, advanced maternal age, and use of dopamine are risk factors for hypothyroidism. The infants treated with levothyroxine should be followed up regularly to ensure an appropriate dose.

Identifiants

pubmed: 33059803
pii: 10.7499/j.issn.1008-8830.2005085
pmc: PMC7569004

Substances chimiques

Thyroxine Q51BO43MG4

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

1073-1078

Références

J Pediatr. 2014 Jun;164(6):1296-302
pubmed: 24518164
J Clin Endocrinol Metab. 2013 Nov;98(11):4499-506
pubmed: 23979950
Ann Pediatr Endocrinol Metab. 2019 Mar;24(1):15-21
pubmed: 30943675
Semin Neonatol. 2004 Feb;9(1):3-11
pubmed: 15013471
Pediatrics. 2009 Aug;124(2):e258-68
pubmed: 19581264
Pediatrics. 2014 Apr;133(4):e955-63
pubmed: 24685955
J Clin Endocrinol Metab. 2017 Aug 1;102(8):3050-3055
pubmed: 28637222
Arch Dis Child Educ Pract Ed. 2015 Oct;100(5):260-3
pubmed: 25776656
J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):177-82
pubmed: 25153575
Korean J Pediatr. 2015 Jun;58(6):224-9
pubmed: 26213551
Pediatrics. 2005 Nov;116(5):e613-8
pubmed: 16234230
J Pediatr. 2019 Apr;207:220-225
pubmed: 30579585
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Jan;22(1):37-41
pubmed: 31948522
J Korean Med Sci. 2009 Aug;24(4):627-31
pubmed: 19654943
Clin Biochem. 2014 Jan;47(1-2):16-8
pubmed: 24125878
Data Brief. 2018 Nov 27;21:2510-2514
pubmed: 30560160
Pediatr Neonatol. 2018 Feb;59(1):3-14
pubmed: 28811156
J Clin Endocrinol Metab. 2004 Nov;89(11):5314-20
pubmed: 15531476

Auteurs

Hui Zhang (H)

Department of Pediatrics, Peking University Third Hospital, Beijing 100191, China. jessypupu@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH